Insulin Nasal Spray Eyed As Alzheimer’s Treatment

Every 67 seconds, someone in the U.S. develops Alzheimer’s disease. More than 5 million Americans are living with the condition and it is responsible for around half a million deaths each year. But in a new study, researchers from the Wake Forest Baptist Medical Center in Winston-Salem, NC, reveal they may have found a promising new treatment for the disease – in the form of an insulin nasal spray.

The researchers, led by Suzanne Craft, PhD, professor of gerontology and geriatric medicine at Wake Forest, found the spray may also be effective for patients with mild cognitive impairment (MCI), which is estimated to affect around 10-20% of people over the age of 65.

READ FULL ARTICLE Curated publisher From Medical News Today